pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Overall adverse events in metoclopramide by age group and year

Age group (year) 2013 2014 2015 2016 2017
<1 14(93.3%) 0(0.0%) 1(6.7%) 0(0.0%) 0(0.0%)
1-17 104(30.1%) 71(20.6%) 54(15.7%) 66(19.1%) 50(14.5%)
18-64 5,318(32.5%) 3,533(21.6%) 2,479(15.1%) 2,458(15.0%) 2,589(15.8%)
≥ 65 1,602(27.4%) 1,302(22.3%) 1,239(21.2%) 876(15.0%) 827(14.1%)
Korean J Clin Pharm 2023;33:122-7 https://doi.org/10.24304/kjcp.2023.33.2.122
© 2023 Korean J Clin Pharm